BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17965620)

  • 1. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.
    Dai Z; Weichenhan D; Wu YZ; Hall JL; Rush LJ; Smith LT; Raval A; Yu L; Kroll D; Muehlisch J; Frühwald MC; de Jong P; Catanese J; Davuluri RV; Smiraglia DJ; Plass C
    Genome Res; 2002 Oct; 12(10):1591-8. PubMed ID: 12368252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.
    Smiraglia DJ; Kazhiyur-Mannar R; Oakes CC; Wu YZ; Liang P; Ansari T; Su J; Rush LJ; Smith LT; Yu L; Liu C; Dai Z; Chen SS; Wang SH; Costello J; Ioshikhes I; Dawson DW; Hong JS; Teitell MA; Szafranek A; Camoriano M; Song F; Elliott R; Held W; Trasler JM; Plass C; Wenger R
    BMC Genomics; 2007 Nov; 8():446. PubMed ID: 18053125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma.
    Wimmer K; Zhu Xx XX; Rouillard JM; Ambros PF; Lamb BJ; Kuick R; Eckart M; Weinhäusl A; Fonatsch C; Hanash SM
    Genes Chromosomes Cancer; 2002 Mar; 33(3):285-94. PubMed ID: 11807986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific methylation profiles occurring disproportionately in CpG-less regions that delineate developmental similarity.
    Sakamoto H; Suzuki M; Abe T; Hosoyama T; Himeno E; Tanaka S; Greally JM; Hattori N; Yagi S; Shiota K
    Genes Cells; 2007 Oct; 12(10):1123-32. PubMed ID: 17903172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of radiation-induced aberrant hypomethylation in colon cancer.
    Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
    BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling of DNA methylation in human cancer cells.
    Ogoshi K; Hashimoto S; Nakatani Y; Qu W; Oshima K; Tokunaga K; Sugano S; Hattori M; Morishita S; Matsushima K
    Genomics; 2011 Oct; 98(4):280-7. PubMed ID: 21821115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
    Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
    PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction landmark genome scanning.
    Costello JF; Smiraglia DJ; Plass C
    Methods; 2002 Jun; 27(2):144-9. PubMed ID: 12095273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island methylation status in the EpCAM promoter region and gene expression.
    Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
    Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
    Ren Z; Wang W; Li J
    Int J Oncol; 2016 Feb; 48(2):690-702. PubMed ID: 26647925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.
    Cheng YW; Shawber C; Notterman D; Paty P; Barany F
    Genome Res; 2006 Feb; 16(2):282-9. PubMed ID: 16369045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
    Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
    Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
    Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
    Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
    Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
    Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
    Smiraglia DJ; Plass C
    Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.
    Zardo G; Tiirikainen MI; Hong C; Misra A; Feuerstein BG; Volik S; Collins CC; Lamborn KR; Bollen A; Pinkel D; Albertson DG; Costello JF
    Nat Genet; 2002 Nov; 32(3):453-8. PubMed ID: 12355068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.